Ocrelizumab approved as an injection to treat multiple sclerosis in adults

Contributed by: UK Government and Public Sector

Tags

Government

Multiple Sclerosis

More Like This

MHRA Approves Zolbetuximab

Polish Ministry of Health Approves Reimbursement of POTELIGEO® (mogamulizumab) for Adults Living With Mycosis Fungoides or Sézary Syndrome

Preliminary Clinical Data on Relma-Cel Injection in Adults with Active Systemic Lupus Erythematosus in China at the Eular 2024 Congress

Kyowa Kirin and Swixx BioPharma announce expansion of access to POTELIGEO® (mogamulizumab) for adults living with mycosis fungoides or Sézary syndrome in Central and Eastern Europe

Camurus' Oczyesa® receives marketing authorization for treatment of acromegaly in the EU

Lecanemab licensed for adult patients in the early stages of Alzheimer’s disease

CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU

Celltrion receives European Commission approval of Omlyclo® (CT-P39), the first and only omalizumab biosimilar approved in Europe